Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Clinical trial NCT06527872 · RECRUITING

Trial details

NCT number: NCT06527872
Sponsor: GlaxoSmithKline
Status: RECRUITING
Study type: OBSERVATIONAL

Lupus Nephritis

Start date: 2024-10-04
Primary completion: 2029-03-29
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.